Prawo i regulacje · 24/09/2007

DEA Proposes Amendment to Schedule III Controlled Substances List

The U.S. Drug Enforcement Administration (DEA) is proposing a change to its schedule III controlled substances list, which includes a specific formulation of a drug product approved by the FDA, to include generic drug products that reference the existing list.